News
Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...
Dexpramipexole targets eosinophilic inflammation Knopp Biosciences’ investigational, first-in-class drug, dexpramipexole, holds promise for patients with asthma and eosinophil-associated diseases.
The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.
People with eosinophilic esophagitis may benefit from managing their diet to control their exposure to trigger foods. Learn more about elimination diets here.
The Many Ways to Measure the Severity of Atopic Dermatitis — Validated physician-reported tools are often complicated, but patient-based measures are easy and informative ...
The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...
A long-running partnership between digital therapeutics (DTx) developer Sidekick Health and Pfizer has resulted in a new app to support patients with atopic dermatitis, which will start rolling ...
J&J agrees to buy Numab subsidiary Yellow Jersey and its NM26 bispecific antibody for atopic dermatitis in a $1.25bn deal.
What’s the Difference Between Eczema and Atopic Dermatitis? Board-certified dermatologist Andrew Alexis, MD, explains similarities and differences between the two.
Here are 7 foods to consider avoiding for babies and toddlers with eczema. Keep in mind that it’s always best to speak with a healthcare professional before eliminating foods from your child’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results